Use of Bone Morphogenetic Protein in Pediatric Cranioplasty With Pre- and Postoperative Radiation Therapy
Jyoti Sharma1, Fatma Betul Tuncer, Barbu Gociman
1University of Utah, Salt Lake City, UT.
Insights
This study shows that recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) can safely and effectively promote bone regeneration in pediatric patients with complex calvarial defects, offering a promising solution for craniofacial reconstruction.
Area of Science:
- Craniofacial surgery
- Orthopedic surgery
- Regenerative medicine
Background:
- Bone morphogenetic protein (BMP) is crucial for bone repair and widely used in orthopedic surgery.
- Its application in craniofacial surgery is increasing, but data in pediatric populations is limited.
- This study addresses the use of BMP in a pediatric craniofacial defect case.
Introduction:
Bone morphogenetic protein (BMP) is a signaling protein that has proven efficacy in the setting of bone repair. It has been widely used in orthopedic surgery and is being implemented more in the field of craniofacial surgery, although there is limited report on its use in pediatric patients.
Case:
A 6-year-old female with stage IV neuroblastoma with metastasis to the parietal parasagittal calvarium, which had failed to respond to multiple medical therapies, including radiation therapy. The tumor was excised and the defect was replaced with a combination of split calvarial bone graft and rhBMP-2. The patient received post-operative radiation therapy with no reports of complications of the defect site on immediate and long term follow up.
Conclusion:
The use of BMP has the potential to aid in bone generation for high-risk calvarial defects. It can be safe and efficacious to use in the pediatric population; however, future studies should be done to determine the safest and most effective dosing of BMP.
